Type 2 diabetes mellitus prevalence and risk scores in treated PLWHIV: a cross-sectional preliminary study

OBJECTIVE: This was a preliminary study whose objective was to estimate the prevalence and risk of developing type 2 diabetes mellitus (T2DM) among people living with HIV (PLWHIV) based on diabetes risk assessment scores. RESULTS: The study was composed of 234 PLWHIV with median age (interquartile r...

Descripción completa

Detalles Bibliográficos
Autores principales: Masenga, Sepiso K., Toloka, Paul, Chiyenu, Kaseya, Imasiku, Ilubala, Mutengo, Hope, Ulungu, Oscar Ngongo, Mallesu, Zangi, Mulenga, Eunice, Mutukwa, Macwañi, Kamvuma, Kingsley, Hamooya, Benson M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420761/
https://www.ncbi.nlm.nih.gov/pubmed/30876484
http://dx.doi.org/10.1186/s13104-019-4183-6
_version_ 1783404135413972992
author Masenga, Sepiso K.
Toloka, Paul
Chiyenu, Kaseya
Imasiku, Ilubala
Mutengo, Hope
Ulungu, Oscar Ngongo
Mallesu, Zangi
Mulenga, Eunice
Mutukwa, Macwañi
Kamvuma, Kingsley
Hamooya, Benson M.
author_facet Masenga, Sepiso K.
Toloka, Paul
Chiyenu, Kaseya
Imasiku, Ilubala
Mutengo, Hope
Ulungu, Oscar Ngongo
Mallesu, Zangi
Mulenga, Eunice
Mutukwa, Macwañi
Kamvuma, Kingsley
Hamooya, Benson M.
author_sort Masenga, Sepiso K.
collection PubMed
description OBJECTIVE: This was a preliminary study whose objective was to estimate the prevalence and risk of developing type 2 diabetes mellitus (T2DM) among people living with HIV (PLWHIV) based on diabetes risk assessment scores. RESULTS: The study was composed of 234 PLWHIV with median age (interquartile range, IQR) of 44 (36, 52) and a female preponderance of 66%. The median risk scores (IQR) for developing T2DM was 5 (2, 9). Based on the risk scores, 5% of PLWHIV were at high risk for developing T2DM close to 3.4% actual prevalence in the study population. This study demonstrated the importance of using a cheap and fast method for identifying high risk individuals for developing T2DM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-019-4183-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6420761
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64207612019-03-28 Type 2 diabetes mellitus prevalence and risk scores in treated PLWHIV: a cross-sectional preliminary study Masenga, Sepiso K. Toloka, Paul Chiyenu, Kaseya Imasiku, Ilubala Mutengo, Hope Ulungu, Oscar Ngongo Mallesu, Zangi Mulenga, Eunice Mutukwa, Macwañi Kamvuma, Kingsley Hamooya, Benson M. BMC Res Notes Research Note OBJECTIVE: This was a preliminary study whose objective was to estimate the prevalence and risk of developing type 2 diabetes mellitus (T2DM) among people living with HIV (PLWHIV) based on diabetes risk assessment scores. RESULTS: The study was composed of 234 PLWHIV with median age (interquartile range, IQR) of 44 (36, 52) and a female preponderance of 66%. The median risk scores (IQR) for developing T2DM was 5 (2, 9). Based on the risk scores, 5% of PLWHIV were at high risk for developing T2DM close to 3.4% actual prevalence in the study population. This study demonstrated the importance of using a cheap and fast method for identifying high risk individuals for developing T2DM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-019-4183-6) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-15 /pmc/articles/PMC6420761/ /pubmed/30876484 http://dx.doi.org/10.1186/s13104-019-4183-6 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Masenga, Sepiso K.
Toloka, Paul
Chiyenu, Kaseya
Imasiku, Ilubala
Mutengo, Hope
Ulungu, Oscar Ngongo
Mallesu, Zangi
Mulenga, Eunice
Mutukwa, Macwañi
Kamvuma, Kingsley
Hamooya, Benson M.
Type 2 diabetes mellitus prevalence and risk scores in treated PLWHIV: a cross-sectional preliminary study
title Type 2 diabetes mellitus prevalence and risk scores in treated PLWHIV: a cross-sectional preliminary study
title_full Type 2 diabetes mellitus prevalence and risk scores in treated PLWHIV: a cross-sectional preliminary study
title_fullStr Type 2 diabetes mellitus prevalence and risk scores in treated PLWHIV: a cross-sectional preliminary study
title_full_unstemmed Type 2 diabetes mellitus prevalence and risk scores in treated PLWHIV: a cross-sectional preliminary study
title_short Type 2 diabetes mellitus prevalence and risk scores in treated PLWHIV: a cross-sectional preliminary study
title_sort type 2 diabetes mellitus prevalence and risk scores in treated plwhiv: a cross-sectional preliminary study
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420761/
https://www.ncbi.nlm.nih.gov/pubmed/30876484
http://dx.doi.org/10.1186/s13104-019-4183-6
work_keys_str_mv AT masengasepisok type2diabetesmellitusprevalenceandriskscoresintreatedplwhivacrosssectionalpreliminarystudy
AT tolokapaul type2diabetesmellitusprevalenceandriskscoresintreatedplwhivacrosssectionalpreliminarystudy
AT chiyenukaseya type2diabetesmellitusprevalenceandriskscoresintreatedplwhivacrosssectionalpreliminarystudy
AT imasikuilubala type2diabetesmellitusprevalenceandriskscoresintreatedplwhivacrosssectionalpreliminarystudy
AT mutengohope type2diabetesmellitusprevalenceandriskscoresintreatedplwhivacrosssectionalpreliminarystudy
AT ulunguoscarngongo type2diabetesmellitusprevalenceandriskscoresintreatedplwhivacrosssectionalpreliminarystudy
AT mallesuzangi type2diabetesmellitusprevalenceandriskscoresintreatedplwhivacrosssectionalpreliminarystudy
AT mulengaeunice type2diabetesmellitusprevalenceandriskscoresintreatedplwhivacrosssectionalpreliminarystudy
AT mutukwamacwani type2diabetesmellitusprevalenceandriskscoresintreatedplwhivacrosssectionalpreliminarystudy
AT kamvumakingsley type2diabetesmellitusprevalenceandriskscoresintreatedplwhivacrosssectionalpreliminarystudy
AT hamooyabensonm type2diabetesmellitusprevalenceandriskscoresintreatedplwhivacrosssectionalpreliminarystudy

Ejemplares similares